Home
>
National Drug Code (NDC)
>
ADCETRIS
ADCETRIS - 51144-050-01 - (brentuximab vedotin)
Drug Information of ADCETRIS
| Product NDC: | 51144-050 |
| Proprietary Name: | ADCETRIS |
| Non Proprietary Name: | brentuximab vedotin |
| Active Ingredient(s): | 50 mg/10.5mL & nbsp; brentuximab vedotin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ADCETRIS
| Product NDC: | 51144-050 |
| Labeler Name: | Seattle Genetics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125388 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110825 |
Package Information of ADCETRIS
| Package NDC: | 51144-050-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) > 10.5 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of ADCETRIS
| NDC Code | 51144-050-01 |
| Proprietary Name | ADCETRIS |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) > 10.5 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 51144-050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | brentuximab vedotin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110825 |
| Marketing Category Name | BLA |
| Labeler Name | Seattle Genetics, Inc. |
| Substance Name | BRENTUXIMAB VEDOTIN |
| Strength Number | 50 |
| Strength Unit | mg/10.5mL |
| Pharmaceutical Classes | CD30-directed Antibody Interactions [MoA],CD30-directed Immunoconjugate [EPC],Immunoconjugates [Chemical/Ingredient],Microtubule Inhibition [PE] |
